Home Blog Page 306

Rebel Moon: Zack Snyder’s two sci-fi films will get two cuts each to cover a wide range of audiences

0
Rebel Moon: Zack Snyder’s two sci-fi films will get two cuts each to cover a wide range of audiences

When Zack Snyder’s sci-fi epic Rebel Moon comes to Netflix, two versions of both films will be available to fans.

Zack Snyder fans will eat well when the filmmaker’s Rebel Moon comes to Netflix in multiple forms. You heard me. In addition to splitting the sci-fi epic into two films, Snyder is creating multiple cuts of each. In an in-depth look at the film, courtesy of Vanity Fair, Snyder explains his Rebel Moon strategy and how he aims to cover a wide range of audiences with each release. One cut is a presentation that “anyone can enjoy and watch,” while the other is an explicit version aimed at adults.

In addition to Vanity Fair‘s in-depth report, the outlet shared a gallery of first-look images for the upcoming sci-fi epic. You can check out select photos from their coverage below:

Rebel Moon, Zack Snyder, Netflix
Rebel Moon, Zack Snyder, Netflix
Rebel Moon, Zack Snyder, Netflix

“I think for fans of mine and people who are ready to take a deeper, harder dive, that’ll be fun for them,” Snyder says about his goal for the more mature cut. Initially, Rebel Moon was going to be one film. However, when Snyder submitted a 174-page script, he realized splitting the story into two presentations would be best. Studies show that two-hour movies fare better than three-hour epics. Considering these metrics, Snyder (and Netflix) think dividing the story into two films will yield better results.

Speaking with Vanity Fair about viewing habits and maximizing Rebel Moon‘s appeal, producer Deborah Snyder said, “[Netflix film chairman Scott] Stuber was like, ‘On the service, under-two-hour movies really do better for some reason,’ even though you’ll binge-watch a series of eight episodes. Zack said, ‘If you ask me to make this less than two hours, I’m going to lose all the character. You won’t care about these people. It’s a character story about how people can change, and redemption, and what are you willing to fight for…’ So he said, ‘What if I give you two movies?’”

Rebel Moon is Snyder’s passion project. Ideas for the story have been floating around his head for over three decades. Thankfully, the time has finally come for Snyder to realize his vision using the latest special effects and the reach of Netflix’s streaming platform.

Rebel Moon, Zack Snyder, Netflix
Rebel Moon, Zack Snyder, Netflix

Here’s the official synopsis for Rebel Moon:

Rebel Moon is a Seven Samurai—inspired space epic about a distant galactic colony that comes under threat from the armies of a tyrannical regent named Balisarius. Desperate to survive, they send a young woman (Sofia Boutella) on a mission to find allies that may be able to turn the tide. The film stars a murderer’s row of talent alongside Boutella, including Charlie Hunnam, Djimon Hounsou, Ed Skrein, Michiel Huisman, Doona Bae, Ray Fisher, Cary Elwes, Alfonso Herrera, Jena Malone, and Sir Anthony Hopkins as (of course) the voice of sentient battle robot Jimmy. Snyder directs and produces alongside Deborah Snyder and Wesley Coller. He co-wrote the script with Kurt Johnstad and Shay Hatten (Day Shift, Army of the Dead).

Are you excited about Zack Snyder’s Rebel Moon? Which version of the story will you watch? Let us know in the comments below. Rebel Moon lands on Netflix on December 2, 2023.

Originally published at https://www.joblo.com/rebel-moon-two-cuts/

Scream 7: Melissa Barrera wants to explore Samantha Carpenter’s mental health

0
Scream 7: Melissa Barrera wants to explore Samantha Carpenter’s mental health

Melissa Barrera is hoping to explore the mental health of her character Samantha Carpenter further in Scream 7

https://www.youtube.com/watch?v=bdDTRZKBYY8

Scream (2022) and Scream VI star Melissa Barrera has previously said that if there is a Scream 7, she would like to see Salma Hayek take on the role of the mother of her character Samantha Carpenter and her half-sister Tara, played by Jenna Ortega. During an interview with Digital Spy, Barrera added that she would also like to get the chance to explore Sam’s mental health even further in a future sequel.

She said, “There are so many places that [Sam] could go. That’s one of the reasons that, when I read the script for Scream 5, I was so interested in the character. There’s so much potential here of where she could go with her mental health – she’s just unpredictable. I find that that darkness in her makes her that much more interesting to play and to watch. She’s the hero but she’s also kind of the villain. It’s this contradiction in her that I find fascinating and, if we get to do another one, I would love to see. The writers have done a really good job with her up until this point, so I trust them just to know where to take her [in a way] that will be unexpected and cool for the fans.

Sam is quite a troubled character, as her father was the Ghostface slasher Billy Loomis (played by Skeet Ulrich) from the original Scream, and she keeps having hallucinations of him where he tries to give her violent life advice.

Paramount Pictures and Spyglass Media haven’t confirmed whether or not they intend to give a greenlight to Scream 7, but since Scream VI was an even bigger hit than the previous movie, chances are good that we’ll be seeing another sequel very soon. Maybe they’re just waiting for Barrera and directors Matt Bettinelli-Olpin and Tyler Gillett to finish working on the Universal Monsters project they’re currently collaborating on, a project that was formerly known as Dracula’s Daughter.

Would you like to see the Carpenter sisters come back for Scream 7? What else would you like to see in the next Scream sequel? Let us know by leaving a comment below.

Originally published at https://www.joblo.com/scream-7-mental-health/

Partial Hospital Program Now Open: Comprehensive Mental Health Care Available for Patients

0
Partial Hospital Program Now Open: Comprehensive Mental Health Care Available for Patients
Oasis Psychiatric Day Program Achieves Prestigious Behavioral Health Care and Human Services Accreditation from The Joint Commission

Oasis Psychiatric Day Program proudly announces that it has been awarded The Joint Commission's Gold Seal of Approval® for Behavioral Health Care and Human Services Accreditation. This esteemed accreditation reflects Oasis' unwavering commitment to delivering exceptional patient care while upholding the highest quality and safety standards.

Undergoing a rigorous onsite review on May 24th and 25th, 2023, Oasis Psychiatric Day Program demonstrated continuous compliance with The Joint Commission's performance standards. Areas of evaluation included emergency management, environment of care, infection prevention and control, leadership, medication management, and individual rights and responsibilities.

The Joint Commission's standards are developed in consultation with renowned health care experts, providers, and patients, ensuring evidence-based guidelines to enhance performance and improve patient outcomes. The surveyors conducted onsite observations and interviews to assess the program comprehensively.

"We are honored to receive this prestigious accreditation from The Joint Commission," expressed Dr. Mathews Thomas, MD, who leads Oasis Psychiatric Day Program. "In the wake of the COVID-19 pandemic, the demand for mental health treatment has skyrocketed. With this accreditation, we are ready to meet the growing needs of our community, offering compassionate and evidence-based Intensive Outpatient and Partial Hospitalization Programs."

Oasis Psychiatric Day Program provides community-based, compassionate care through its superior quality Psychiatric Partial Hospital and Intensive Outpatient Programs. With a focus on comfort and personalized treatment outside of the traditional hospital setting, Oasis is committed to making a positive impact on the lives of individuals in the community and surrounding areas.

"As a heath care accreditor, The Joint Commission works with health care organizations across settings to help improve patient safety and quality of care through our expert resources and tools, innovative solutions and rigorous standards," says Deborah Ryan, MS, RN, interim executive vice president, Accreditation and Certification Operations, The Joint Commission. "We commend Psychiatric Day Program for its commitment to advance safety and quality for all patients."

Contact Information:
Mathews Thomas
Medical Director
[email protected]
7819807600

Nadolphia Andou
Clinical Director of Operations
[email protected]
7819807600
Related Files
Oasis Press Release.docx
Blue Professional Mental Health College Brochure (1).pdf



Original Source: Partial Hospital Program Now Open: Comprehensive Mental Health Care Available for Patients

Expend4bles: A new poster brings punk rock vibes to the action-hero ensemble sequel

0
Expend4bles: A new poster brings punk rock vibes to the action-hero ensemble sequel

A new Expend4bles poster brings punk rock energy to the action-packed sequel led by Sylvester Stallone and Jason Statham.

Spider-Man: Across the Spider-Verse isn’t the only movie bringing punk rock vibes to theaters this year. Lionsgate debuted a new poster for Expend4bles, the fourth chapter of the Expendables franchise that makes you want to throw up your horns and bang your head. The Expend4bles poster features a neon skull with a mohawk made of weapons! As a fire burns inside the skull, guns and knives protrude from almost every angle, as if Ghost Rider became an NRA poster boy. Included are the names of various cast members, from Stallone to Statham, Jaa, Uwais, Fox, and more!

After wrapping his part in Expend4bles, Stallone announced that his fourth film in the action-packed franchise is his last. “It’s time to be movin’ on” from The Expendables. Stallone added that he’s “ready to pass the baton on to Jason [Statham] and his capable hands.” Should there be another franchise installment, Staham might be the new face of the series. As Stallone walked through the set, he spoke of the “heart, energy, and humour” he hopes to bring to all his projects.

“The greatest thing is being able to provide films and entertainment [where] maybe there’s a little message in there, because what I try to convey in my successful films is the human touch, the bond,” Stallone said while reflecting on his time as the Expendables leader, Barney Ross. “Not so much the action, the action is self-evident, but just relating to the audience in a way they can identify with whatever the mission is with the characters at hand.”

Although Sylvester Stallone says he’s finished with The Expendables, he teased that he’s “getting ready to accept the next challenge.” The Expend4bles will feature Sylvester Stallone, Jason Statham, Dolph Lundgren, Randy Couture, Megan Fox, Tony Jaa, Curtis “50 Cent” Jackson, and Andy Garcia. Scott Waugh directs from a screenplay by Spenser Cohen with revisions by Max Adams and John Joseph Connolly.

What do you think about the new Expend4bles poster? Is Jason Statham ready to accept the baton from Stallone? How many more sequels or spin-offs will come from the Expendables franchise? Please feel free to sound off in the comments below.

Expend4bles, poster, Lionsgate

Originally published at https://www.joblo.com/expend4bles-poster/

Alera Group’s Veterinary Division Revolutionizes Employee Benefits and Insurance With Comprehensive Solutions for Animal Hospitals

0
Alera Group’s Veterinary Division Revolutionizes Employee Benefits and Insurance With Comprehensive Solutions for Animal Hospitals

Alera Group, which supports veterinary practices by offering employee benefits and insurance, takes a focused approach to employee benefits and insurance, offering comprehensive solutions designed specifically for veterinary professionals. With a deep understanding of the unique challenges faced by those in the veterinary industry, Alera is committed to providing tailored benefits packages that prioritize the well-being and financial security of veterinary professionals.

Recognizing the crucial role that veterinarians, veterinary technicians, and support staff play in the health and well-being of our beloved pets, Alera has developed an extensive suite of benefits and insurance options to meet their diverse needs. Its innovative platform combines cutting-edge technology with personalized support to simplify the process of accessing and managing these essential resources.

Alera's employee benefits program includes a wide range of offerings, such as comprehensive health insurance plans, dental and vision coverage, disability insurance, and more. Additionally, Alera partners with leading insurance providers to ensure that veterinary professionals have access to competitive rates and robust coverage options.

"Alera Group's Veterinary Division is dedicated to supporting veterinary professionals by providing them with the comprehensive benefits and insurance coverage they deserve," said Cory Friedman, Managing Director at Alera Group. "We understand the unique challenges faced by those in the veterinary industry, and our mission is to alleviate some of that burden by offering customized solutions that protect their health, financial well-being, and peace of mind."

The Alera Team's commitment to the veterinary community extends beyond benefits and insurance. They are actively engaged in ongoing research and collaboration with industry partners to develop innovative solutions that address the evolving needs of veterinary professionals.

For more information about Alera and its unique employee benefits and insurance offerings, please visit https://aleravet.com/ or contact Cory Friedman at [email protected].

Contact Information:
Cory Friedman
Managing Director, Veterinary Division
[email protected]
224-628-8682


Original Source: Alera Group's Veterinary Division Revolutionizes Employee Benefits and Insurance With Comprehensive Solutions for Animal Hospitals

MedTech Clinical and Data Science Leaders Come Together to Introduce 3Aware and a First-of-Its-Kind Solution for Post-Market Clinical Follow-Up

0
MedTech Clinical and Data Science Leaders Come Together to Introduce 3Aware and a First-of-Its-Kind Solution for Post-Market Clinical Follow-Up

Company leaders today announced the launch of 3Aware, formed by leading scientists and technologists from the MedTech and HealthTech sectors. 3Aware is committed to enhancing the availability, safety and performance of medical devices while decreasing the time, cost and risk associated with post-market clinical follow-up (PMCF) and active surveillance.

Medical device manufacturers indicate costs associated with new post-market surveillance regulations in the EU will equal 5% or more of their annual market revenues. As other regulators adopt similar approaches, the annual $500B global medical device industry could see compliance spending increase by $25B above current levels over the next several years.  

3Aware was created when a leading global medical device company, Cook Medical, recognized the need for an industry-wide solution to this unsustainable trend and sought out a leading HealthTech innovator, Health Cloud Ventures (HCV), to establish a new, independent company focused specifically on optimizing post-market clinical follow-up and active surveillance for MedTech companies. 

Cook and HCV combined their respective expertise to set 3Aware on a path to revolutionize how MedTech companies leverage healthcare data, by longitudinally connecting specific patient outcomes to specific devices, across large populations—a new method called aiSurveillance. This breakthrough approach is implemented within a seamless user experience designed to optimize the access, efficiencies and insights of clinical scientists.  

"3Aware presents a tremendous opportunity to solve real-world business challenges for MedTech—to decrease costs, drive efficiency and simplify the challenges of PMCF reporting," said Rob Lyles, President of Cook Ventures and a 3Aware board member. 

"3Aware is delivering a breakthrough in the application of Reinforcement Learning from Human Feedback (RLHF) artificial intelligence (AI) to power clinical interpretation and resulting insights that demonstrate real-world safety and performance—a game-changer for our industry," added Brad Bostic, Executive Chairman of 3Aware and CEO of Health Cloud Ventures.

3Aware aiSurveillance—aided by Natural Language Processing (NLP)—facilitates regulatory compliance, as outlined by European Union Medical Device Regulation (EU MDR) and the International Medical Device Regulators Forum (IMDRF, which includes the FDA) Post-Market Clinical Follow-Up Studies. aiSurveillance will also help to accelerate MedTech market share growth, by enhancing market access, label expansion and product portfolio optimization. 

3Aware is also pleased to announce the appointment of Chris Brown as its President & Chief Operating Officer (COO) to assume oversight of business operations and overall execution across the company. Brown is the former COO of hc1 and former VP of Customer Operations at Sprint Nextel. He has held a variety of leadership roles in sales operations, finance, customer care and strategic planning. Additionally, 3Aware has appointed Amelia Hufford, Ph.D., as Senior Vice President of Clinical & Regulatory Science Operations. Dr. Hufford brings a wealth of experience in scientific research, clinical and regulatory affairs, and MedTech post-market strategy. 

###

About 3Aware

3Aware enables MedTech manufacturers to achieve compliance at a fraction of the time, cost and risk of status quo approaches—by enabling highly-efficient access to longitudinal patient-level data, including conditions, treatments, encounters, procedures and outcomes, directly related to the use of specifically identified medical devices.  

  • 3Aware data currently covers millions of patients, relative to tens of thousands of devices, and is consistently growing.  
  • Proven AI capabilities facilitate the mining, interpretation and structuring of critical information buried in unstructured provider notes.
  • The 3Aware platform enables analysts to quickly and directly access the content they need to apply their expertise—in an environment optimized for Post-Market Clinical Follow-up. 

Learn more at 3aware.ai/preview.

Contact Information:
Phil Stoltzfus
Senior Director of Marketing
[email protected]
12672400033


Original Source: MedTech Clinical and Data Science Leaders Come Together to Introduce 3Aware and a First-of-Its-Kind Solution for Post-Market Clinical Follow-Up

Isto Biologics Launches Precise – the Newest Advancement in Autologous Therapies

0
Isto Biologics Launches Precise – the Newest Advancement in Autologous Therapies
New Precise™ technology provides physicians with more options for custom PRP


Precise

Precise\u2122 - a new advancement in autologous therapies

Isto Biologics, a leader in orthobiologic regeneration technologies and cell-based therapies that focuses on helping patients heal faster, announced today the launch of Precise™, a brand-new, state-of-the-art technology that delivers a final PRP product with precision cellular fractions upon concentration.

The Precise system's CellectFlex™ Technology allows for tailored cell compositions with each spin, allowing the system to provide a targeted range of offerings that have never been available before.

"We are excited to introduce this novel addition to our line of autologous therapies," said Don Brown, Isto's Chief Executive Officer. "Precise offers physicians and surgeons the ability to customize their PRP to fit their patient needs."

The Precise system utilizes patented technology that offers solutions to obtain both leukocyte-poor and leukocyte-rich PRP outputs. In a single spin, Precise can deliver a low hematocrit and granulocyte count, all while delivering a high platelet and mononucleated cell concentrate.

"This exciting new product is a direct result of listening to the needs of our customers," said Brian Barnes, PhD, President at Isto Biologics. "We are in a constant pursuit to deliver products that change the lives of patients and believe that Precise will keep physician and patient needs front and center with no compromise."

Current Precise Offerings

Precise Sapphire - The Precise Sapphire kit will provide a leukocyte-rich PRP, with a final PRP output that equates to 'the perfect PRP' based on platelet concentration, mononucleated cells, granulocytes and hematocrit counts.

Precise Diamond - The Precise Diamond kit will provide a leukocyte-poor PRP and further reduces the inflammatory cell fractions being the neutrophils (granulocytes) and hematocrit all while capturing therapeutic concentrations of platelets (growth factors) and elevating mononucleated cells above baseline.

About Isto Biologics

Isto Biologics is a leading biologics and cellular therapy company in the orthopedic space. Isto Biologics is focused on Helping Patients Heal Faster™ through innovative solutions for bone regeneration and cell-based therapies. The company's flagship product offerings include the market-leading Magellan® Autologous Platelet Separator, and bone graft products including InQu® Bone Graft Extender & Substitute, and the Influx™ product family.

For more information, visit  istobiologics.com 

Contact Information:
Jessica Kemp
Marketing Director
[email protected]
774-230-7125


Original Source: Isto Biologics Launches Precise - the Newest Advancement in Autologous Therapies

BeMe.ai Announces Addition of COO Timothy Wackenreuter

0
BeMe.ai Announces Addition of COO Timothy Wackenreuter

BeMe.ai COO Timothy Wackenreuter

BeMe.ai COO Timothy Wackenreuter

The BeMe team is pleased to announce the addition of Timothy Wackenreuter as Chief Operating Officer.

Tim brings a breadth of experience and deep expertise in building strong operations within scaling startup companies.  Most recently Tim held executive roles with NewStar Capital and startups Lighter Nutrition (health-tech) and Closed Loop Partners (circular economy). 

Tim's track record demonstrates what it means to be a servant leader - a role he has occupied well at each company. 

Tim is passionate about his work but also about family. Tim is the proud uncle, and sometimes caregiver of Liam, a loving and creative 10-year-old Autistic child. 

Tim has been a mentor to Autism-focused ventures as part of the Multiple Hub, Inc. mentorship program.

A native of Essex, Connecticut, Tim is a graduate of Wittenberg University in Ohio. 

"As a family member of an Autistic child, I have witnessed the difficulties that come with navigating the complex and disjointed system of care.  I have been searching for a technology like BeMe.ai, which gives the care team actionable data to help the acute issues that children and families may face every day."

"I am excited to roll up my sleeves and get to work building the processes and infrastructure necessary to support this high-growth business. BeMe's mission is one that I am 100% behind. I feel a special privilege that this role allows me to combine personal passion and connection with their mission, and I am so pleased to be able to do so," shared Tim.

"We are truly excited to have Tim on board and leading our operations as we continue in our growth as a company.  It is key to have strong alignment on all fronts - I could not be prouder of the team that we have assembled and where Tim is going to help take us," concluded Sarah Glofcheskie, BeMe's Founder and CEO. 

--

About BeMe

BeMe.ai is focused on bridging the gap between the current standard of care provided to Autistic individuals and a truly individualized, needs-based approach to holistic well-being on a massive scale.

BeMe provides a health and well-being tracker and insight-generating app incorporating medical, behavioral and environmental data, designed specifically to support Autistic children. 

Contact Information:
Sarah Glofcheskie
Founder and CEO, BeMe.ai
[email protected]
+1.647.223.5322
Related Files
Press Release - BeMe Announces COO Timothy Wackenreuter.pdf



Original Source: BeMe.ai Announces Addition of COO Timothy Wackenreuter

Chris Hemsworth talks about Thor 4 and Marvel criticisms from high-profile filmmakers

0
Chris Hemsworth talks about Thor 4 and Marvel criticisms from high-profile filmmakers

Chris Hemsworth talks about Thor 4 and Marvel criticisms from high-profile filmmakers

Originally published at https://www.joblo.com/chris-hemsworth-marvel-critisisms/

Waystar Earns Top Client-Rated Revenue Cycle Management End-to-End Software Solution Set for Hospitals, IDNs and Health Systems, 2023 Black Book Survey

0
Waystar Earns Top Client-Rated Revenue Cycle Management End-to-End Software Solution Set for Hospitals, IDNs and Health Systems, 2023 Black Book Survey

Black Book Research announced that Waystar has been named the leading vendor for Revenue Cycle Management Software Technology for Large Hospitals & Academic Medical Centers as well as Health Systems, Chains, and IDNs, acknowledged by RCM solutions clients in the 2023 RCM survey responses of 1,902 hospital executives, financial system users, and business office leaders from 680 inpatient organizations.

From Q4 2022 through Q2 2023, the Black Book Research financial digital transformation software client/user survey investigated 307 finance functional category vendors utilized by a total of 5,895 validated client users for the solutions vendor ratings. 

In a marketplace of several hundred core and niche Revenue Cycle Management (RCM) solutions vendors, the current Black Book survey respondents evaluated healthcare provider technology tools. Waystar's business units, including Navicure, Zirmed, Recondo, Connance, Patientco and eSolutions, have been top-rated by customers in the Black Book annual survey processes for over a decade, with top client satisfaction ratings since 2012.

Waystar scored highest in 12 of 18 revenue cycle management key performance indicators, including Strategic Alignment of Client Goals; Innovation; Training; Trust, Transparency, Accountability; Breadth of offerings; Deployment and implementation; Customization; Brand image and marketing communications; Marginal value adds; Viability, Managerial Stability; Support and customer care; and Best of breed technology and process improvement.

Full results can be found at https://blackbookmarketresearch.com/finance-revenue-cycle-management.

Black Book conducts crowdsourced polls and surveys with healthcare executives and front-line users about their current technology trends, and services partners and awards top-performing vendors' recognition based on performance using indicators of client experience, loyalty, and customer satisfaction.

About Black Book

Black Book™, its founder, management, and staff do not own or hold any financial interest in any of the vendors covered and encompassed in the RCM surveys it conducts, including Waystar. Black Book reports the results of the collected satisfaction and client experience rankings in publication and to media prior to vendor notification of rating results and does not solicit vendor participation fees, review fees, inclusion or briefing charges, and/or vendor collaboration as Black Book polls vendors' clients.

For methodology, auditing, resources, comprehensive research, and ranking data, see www.blackbookmarketresearch.com or contact us at [email protected].

Contact Information:
Press Office
[email protected]
8008637590


Original Source: Waystar Earns Top Client-Rated Revenue Cycle Management End-to-End Software Solution Set for Hospitals, IDNs and Health Systems, 2023 Black Book Survey